Bioter S.A.

AT:BIOT Greece Engineering & Construction
Market Cap
$3.54 Million
€3.45 Million EUR
Market Cap Rank
#34938 Global
#101 in Greece
Share Price
€0.21
Change (1 day)
+0.00%
52-Week Range
€0.18 - €0.25
All Time High
€0.58
About

Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more

Bioter S.A. (BIOT) - Net Assets

Latest net assets as of December 2022: €-106.17 Million EUR

Based on the latest financial reports, Bioter S.A. (BIOT) has net assets worth €-106.17 Million EUR as of December 2022.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€85.09 Million) and total liabilities (€191.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-106.17 Million
% of Total Assets -124.78%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Bioter S.A. - Net Assets Trend (2014–2022)

This chart illustrates how Bioter S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Bioter S.A. (2014–2022)

The table below shows the annual net assets of Bioter S.A. from 2014 to 2022.

Year Net Assets Change
2022-12-31 €-106.17 Million -10.03%
2021-12-31 €-96.49 Million -10.04%
2020-12-31 €-87.69 Million +6.36%
2019-12-31 €-93.64 Million -10.14%
2018-12-31 €-85.02 Million -19.08%
2017-12-31 €-71.39 Million -31.82%
2016-12-31 €-54.16 Million -52.84%
2015-12-31 €-35.44 Million -39.90%
2014-12-31 €-25.33 Million --

Equity Component Analysis

This analysis shows how different components contribute to Bioter S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 8063700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2022)

Component Amount Percentage
Common Stock €73.13 Million %
Other Components €415.00K %
Total Equity €-106.17 Million 100.00%

Bioter S.A. Competitors by Market Cap

The table below lists competitors of Bioter S.A. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bioter S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from -96,493,000 to -106,170,000, a change of -9,677,000.
  • Net loss of 9,677,000 reduced equity.
  • Other factors decreased equity by 0.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income €-9.68 Million -9.11%
Total Change €- %

Book Value vs Market Value Analysis

This analysis compares Bioter S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 €-5.24 €0.21 x
2021-12-31 €-5.77 €0.21 x
2022-12-31 €-6.34 €0.21 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bioter S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -3840.08%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 0.00% -273.31% 0.04x 0.00x €-10.95 Million
2015 0.00% -829.10% 0.01x 0.00x €-6.59 Million
2016 0.00% -3325.77% 0.01x 0.00x €-12.91 Million
2017 0.00% -9730.56% 0.00x 0.00x €-10.38 Million
2018 0.00% -7229.38% 0.00x 0.00x €-4.31 Million
2019 0.00% -3556.40% 0.00x 0.00x €473.10K
2020 0.00% 2656.58% 0.00x 0.00x €14.83 Million
2021 0.00% -3580.89% 0.00x 0.00x €840.30K
2022 0.00% -3840.08% 0.00x 0.00x €940.00K

Industry Comparison

This section compares Bioter S.A.'s net assets metrics with peer companies in the Engineering & Construction industry.

Industry Context

  • Industry: Engineering & Construction
  • Average net assets among peers: $202,832,885
  • Average return on equity (ROE) among peers: 0.25%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Bioter S.A. (BIOT) €-106.17 Million 0.00% N/A $1.57 Million
Avax S.A (AVAX) $177.41 Million -18.46% 6.39x $179.84 Million
Domiki Kritis S.A. (DOMIK) $13.01 Million 14.49% 1.37x $10.15 Million
Ekter SA (EKTER) $44.08 Million 23.40% 1.07x $55.24 Million
Ellaktor S.A (ELLAKTOR) $974.68 Million 3.42% 1.04x $50.84 Million
Intracom Constructions Societe Anonyme Technical and Steel Constructions (INKAT) $49.93 Million -13.29% 4.77x $423.20 Million
Technical Olympic S.A (OLYMP) $154.35 Million -2.84% 0.27x $36.25 Million
Proodeftiki S.A. (PRD) $6.36 Million -4.94% 2.41x $5.67 Million